Centro Risorse

Questa sezione contiene ricerche internazionali e può fare riferimento a indicazioni non approvate in tutte le regioni. Si prega di consultare le indicazioni approvate localmente prima dell’uso.

Filtra per:

Cerca
  • Comunicati stampa

Pulsenmore announces first commercial engagement with a leading U.S.-based medical center

Pulsenmore intro presentation composition

OMER, Israel, Feb 2, 2026 /PRNewswire/ — Pulsenmore Ltd. (NASDAQ, TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical center in the

Per saperne di più
  • Comunicati stampa

Pulsenmore strategic agreement with Clalit for at-home follicular monitoring

Pulsenmore FC at-home ultrasound for follicular monitoring

Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation Commercial agreement potentially valued at approximately $4.5 million over five years following 18 month

Per saperne di più
  • Newsletter

January 2026 Newsletter

We’re excited to share a few key updates from Pulsenmore as we continue to expand our impact in maternal-fetal care. FDA authorization, and what it unlocks Receiving FDA De Novo

Per saperne di più
  • Notizie

We’re honored to have Prof. Alfred Abuhamad, a global leader in maternal-fetal medicine, on the Pulsenmore advisory board.

Pulsenmore introduces a transformative model for prenatal care - extending ultrasound access beyond the clinic and redefining how we reach and monitor expectant mothers.
Per saperne di più
  • Comunicati stampa, Notizie

FDA De Novo marketing authorization

RAMAT GAN, Israel, Nov. 3, 2025 /PRNewswire/ -- Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted
Per saperne di più
  • Notizie

We are thrilled to announce our collaboration with ARC innovation

We are thrilled to announce our collaboration with ARC Innovation and Dr. Avi (Abraham) Tsur, MD),
Per saperne di più

L’impulso delle notizie

Vi invitiamo a rimanere informati sugli ultimi aggiornamenti iscrivendovi alla nostra newsletter trimestrale

Iscrizione

Domande frequenti

Domande frequenti